Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - lansoprazole - קפסולות - lansoprazole 15 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome.treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (gord) or duodenal ulcer. prevention of relapse in patients with gord or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - aloe; aloin; belladonna dry extract; ipecacuanha; phenolphthalein - טבליה - ipecacuanha 4 mg; belladonna dry extract 2.7 mg; aloin 4.5 mg; aloe 6 mg; phenolphthalein 32 mg - contact laxatives in combination - contact laxatives in combination - constipation.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 2 mg - repaglinide - repaglinide - treatment of type ii diabetes.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - alfacalcidol - טיפות - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - renal bone disease. hypoparathyroidism. rickets and osteomalacia. osteoporosis. primary and tertiary hyperparathyroidism. neonatal hypocalcemia.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - alfacalcidol - קפסולות ג'לטין רכות - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - renal bone disease (renal osteodystrophy), hypoparathyroidism, hyperparathyroidism (with bone disease) - primary and tertiary. neonatal hypocalcemia, rickets and osteomalacia, osteoporosis.